MYD88 and ovarian cancer: CD44+ cells, including CD44+MyD88+ cells from either ascites or tumor tissues [22] and CD44+CD24+EpCAM+ cells from ovarian cancer cell lines [23], exhibit the molecular phenotypes of ovarian CSC/TICs.